Marian L. Waterman

Professor, Microbiology & Molecular Genetics
School of Medicine

Director, Cancer Research Institute

Deputy Director, Chao Family Comprehensive Cancer Center

Associate Director for Basic Science, Chao Family Comprehensive Cancer Center

PH.D., University of California, San Diego

Phone: (949) 824-2885, 3096
Fax: (949) 824-8598

University of California, Irvine
Rm B251 Medical Sciences I
School of Medicine
Mail Code: 4025
Irvine, CA 92697

picture of Marian L. Waterman

Wnt signaling, cancer, gene expression, development, metabolism; intestine; stem cells; pluripotency; LEF and TCF transcription factors
URLs Department of Microbiology and Molecular Genetics
UCI Chao Family Comprehensive Cancer Center
Cellular and Molecular Biosciences Graduate Program
Center for Complex Biosystems
Sue and Bill Gross Stem Cell Center
American Cancer Society Postdoctoral Fellowship
Special Fellow, Leukemia Society
Appointments Post-Doctoral Fellow, The Salk Institute, 1987-1993
The goal of research in the Waterman laboratory is to understand how the Wnt signaling pathway regulates target genes through the actions of LEF/TCF transcription factors. Dysfunctional Wnt signals misregulate gene expression and cause cancer and most of our work on LEF/TCFs is within the context of the final step of this dysregulated pathway. LEF/TCF proteins bind to Wnt Response Elements in target genes and recruit ß-catenin for gene activation or repressors for gene silencing. There are two main areas of research: 1) Regulation of LEF/TCF expression, and 2) Structure and activities of LEF/TCFs. Our work in these two areas has led to new insights on LEF/TCF structure, Wnt response element recognition, signals from the tumor microenvironment and chromatin regulators that modify the types and amounts of LEF/TCFs. In almost every aspect LEF/TCF expression and/or function has been distorted in cancer.

Transcription: The LEF1 locus has two promoters for RNA polymerase II transcription, where each promoter produces a differently acting form of LEF-1. One promoter is activated in Wnt-linked cancers (P1), the other promoter is silenced (P2). We aim to identify the regulatory elements, transcription factors and signaling pathways that create this pattern, as the activated-silenced pattern produces only Wnt-promoting forms of LEF-1. We are also working to define common themes of transcription regulation of all four mammalian LEF/TCFs for a more comprehensive view of expression of this family is modulated during development and disease.
Translation: LEF1 mRNA produced from P1 contains two Internal Ribosome Entry Sites in its long 5’ UTR. We have discovered a cancer-relevant signaling pathway that regulates IRES activity and LEF-1 protein production. Current efforts are focused on a new method to isolate LEF1 mRNA/protein complexes for mass spectrometry analysis and IRES-factor discovery.

A new DNA binding domain: We have discovered a second DNA binding domain in the C-terminus of TCFs. Previously known as the CRARF region, we refer to it as the “C-clamp” because of four invariant and essential cysteines. The C-clamp is a new type of DNA binding domain and appears to be critical for TCF-mediated growth control. We aim to define the role of this domain in carcinogenesis and obtain structural and gene targeting information to develop ways to interfere with its function.
Nuclear export of TCFs: Another major effort in the laboratory is a focus on subcellular trafficking of LEF/TCFs. Our early research identified nuclear localization activities and receptors that ushered LEF/TCFs into the nucleus. More recently, we have discovered that certain mammalian TCFs engage in nuclear/cytoplasmic shuttling – an activity that is active and distorted in cancer. We have discovered a Wnt-linked kinase cascade that can control this shuttling, linking TCF trafficking to extracellular signals that may be aberrant in the tumor microenvironment. The Wnt-linked signal has elements of “canonical” and “non-canonical” signaling, and we are working to define these novel elements as well as the molecular changes in LEF/TCFs when export is triggered.
Publications Hoverter, N.P., M. D. Zeller, M. M. McQuade, A. Garibaldi, A. Busch, E. M. Selwan, K. J. Hertel, P. Baldi, and M.L. Waterman. 2014. The TCF C-clamp DNA Binding Domain Expands the Wnt Transcriptome via Alternative Target Recognition. Nucleic Acids Res. 42(22):13615-32
  Tsai, B.P., J. Jimenez, S. Lim, K.D. Fitzgerald, M. Zhang, C.T.H. Chuah, H. Axelrod, L. Nelson, S. T. Ong, B.L. Semler, and M.L. Waterman. 2014. A Novel Bcr-Abl-mTOR-eIF4A Axis Regulates IRES-Mediated Translation of LEF-1. Open Biology, in press [Epub online: 2014 Nov;4(11). pii: 140180]
  MacDonald B.T., A. Hien, X. Zhang, O. Iranloye, D. M. Virshup, M. L. Waterman, and X. He. 2014. Disulfide Bond Requirements for Active Wnt Ligands. J. Biol. Chem. 289:18122-18136. PMC4140276
  Ehsan S.M., K. M. Welch-Reardon, M.L. Waterman, C.C. Hughes, S.C. George. 2014. A three-dimensional in vitro model of tumor cell intravasation. Integr Biol. 6:603-10. PMC4046910

Journal Cover
  Chodaparambil, J.V., K.T. Pate, M.R.D. Hepla, B.P. Tsai, U.M. Muthurajan, K. Luger, M.L. Waterman, and W.I. Weis. 2014. Molecular Functions of the TLE Tetramerization Domain in Wnt Target Gene Repression. EMBO J, 33:719-31. PMC4000089

Recommended by F1000 Faculty: DOI: 10.3410/f.718299613.793492896
  Pate, K.T., C. Stringari, S. Sprowl-Tanio, K. Wang, T. TeSlaa, N.P. Hoverter, M.M. McQuade, C. Garner, M.A. Digman, M.A. Teitell, R.A. Edwards, E. Gratton, M.L. Waterman. 2014. WNT Signaling Directs a Metabolic Program of Glycolysis and Angiogenesis in Colon Cancer. EMBO J. 33:1454-73. PMC4194089

Highlighted in: Thompson, C.B. 2014. Wnt Meets Warburg: another piece in the puzzle? EMBO J. 33:1420-2.
Recommended by F1000 Faculty:
• DOI:10.3410/f.718387224.793499223
• DOI:10.3410/f.718387224.793499432
  Konstorum, A., S.A. Sprowl, M.L.Waterman, A.D. Lander, J.S. Lowengrub. 2013. Predicting mechanism of biphasic growth factor action on tumor growth using a multi-species model with feedback control. J Coupled Syst Multiscale Dyn. 1(4):459-467. PMC4112130
  Cheng, Y., A.K. Cheung, J.M. Ko., Y.P. Phoon, P.M. Chiu, P.H. Lo, M.L. Waterman, M.L. Lung. 2013. Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol., 14:44. PMC3819748
  Wu*, B., S. Piloto, W. Zeng, N.P. Hoverter, T.F. Schilling, and M.L. Waterman*. 2013. Ring Finger Protein 14 is a novel regulator of TCF/ß-catenin-mediated transcription and colon cancer cell survival. EMBO Rep. 14:347-355. PMC3615654

Highlighted Article in “Hot Off The Press”, Cantu, C. et al. EMBO Rep. 2013 14:295-296.
  Stringari, C., R.A. Edwards, K.T. Pate, M.L. Waterman, P.J. Donovan, E. Gratton. 2012. Metabolic trajectory of cellular differentiation in small intestine by Phasor Fluorescence Lifetime Microscopy of NADH. Sci. Rep. 2:568. PMC3416911
  Najdi, R., K. Proffitt, S. Sprowl, S. Kaur, J. Yu, T.M. Covey, D.M. Virshup*, and M.L. Waterman*. 2012. A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation, 84(2):203-213. PMC4015730
  Hoverter, N.P., J.-H. Ting, S. Sundaresh, P. Baldi, M.L. Waterman. 2012. A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs. Mol. Cell Biol., 32:3648-3662. PMC3430198
  Tsai, B.P., X. Wang, L. Huang, M.L. Waterman. 2011. Quantitative profiling of in vivo-assembled RNA-protein complexes using a novel integrated proteomic approach. Mol Cell Proteomics, 10(4):M110.007385.
  Atcha, F.A., A. Syed, J.E. Munguia, J-H. T. Ting, J.L. Marsh*, and M.L. Waterman*. 2007. Inclusion of a second DNA binding domain by alternative splicing converts TCF-1 and TCF-4 into stronger Wnt effectors. Mol. Cell. Biol. 27:8352-8363

“Recommended” reading on Faculty of 1000 list.
  Sprowl, S. and M.L. Waterman. 2013. Past Visits Present: TCF/LEFs partner with ATFs for ß?catenin independent activity. PLoS Genetics, 9(8):e1003745.
  Hoppler, S. and M.L. Waterman. 2013. Variety of vertebrate TCF/LEF structure, function, and regulation, in: Wnt signaling in Development and Disease: Molecular Mechanisms and Biological Functions (S. Hoppler and R.T. Moon eds.), Wiley Publishers, in press.
  Tsai, B.P., N.P. Hoverter, and M.L. Waterman. 2012. Blending hippo and WNT: sharing messengers and regulation. Cell, 151:1401-3.
  Cadigan, K.M., and M.L. Waterman. 2012. TCF/LEFs and Wnt signaling in the nucleus. Perspectives in Biology (Cold Spring Harbor). 4: doi:pii: a007906
  Najdi, R., R. Holcombe, and M.L. Waterman. 2011. Wnt signaling and colon carcinogenesis: Beyond APC. J. Carcinogenesis, 10:5-10.
  Semler, B. L., and M. L. Waterman. 2008. IRES-mediated pathways to polysomes: nuclear versus cytoplasmic routes. Trends Microbiol.,16:1-5.
  Arce, L., N.N. Yokoyama and M.L. Waterman. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25:7492-7502.
  Semler, B. L., and M. L. Waterman. 2008. IRES-mediated pathways to polysomes: nuclear versus cytoplasmic routes. Trends Microbiol.,16:1-5.
  Najdi, R., R. Holcombe, and M.L. Waterman. 2011. Wnt signaling and colon carcinogenesis: Beyond APC. J. Carcinogenesis 10:5.
  Yokoyama, N., K.T. Pate, S. Sprowl, and M.L. Waterman. 2010. A role for YY1 repression of dominant negative LEF-1 expression in colon cancer. Nucleic Acids Res. 38:6375-88
  Wang, Y., R. Dhopeshwarkar, R. Najdi, M.L. Waterman, C. E. Sims, and N. Allbritton. 2010. Microdevice to capture colon crypts for in vitro studies. Lab on Chip. 10:1596-1603
  Sikandar, S. S., K.T. Pate, S. Anderson, D. Dizon, R.A. Edwards, M.L. Waterman and S.M Lipkin. 2009. NOTCH signaling is required for colon cancer initiating cell tumor formation, self-renewal and repression of secretory cell lineage differentiation. Cancer Res. 70:1469-78.
  Najdi, R., A. Syed, L. Arce, H. Theisen, J.T. Ting, F. Atcha, R.A. Edwards, J.L. Marsh*, M.L. Waterman*. 2009. Nuclear exclusion of growth-suppressing TCF-1 via a Wnt-mediated signal in colon cancer. Oncogene. 28:4133-46
  Arce L., K. T. Pate, M.L. Waterman. 2009. Groucho recognizes a peptide motif in LEF-1 for HDAC-dependent repression in a subset of colon cancers. BMC Cancer, 9:159
  Hoverter, N.P. and M.L. Waterman. 2008. “A Wnt-fall for gene regulation: repression”. Science Signal. 1:43-46
  Yang, M., M.L. Waterman, and R.K. Brachmann. 2008. hADA2 and hADA3 are essential for acetylation, transcriptional activity and proliferative effects of beta-catenin. Cancer Biol. Ther.7: 120-128
  Li, B., C. Rheaume, A. Teng, V. Bilanchone, J.E. Munguia, M. Hu, S. Jessen, S. Piccolo, M.L. Waterman, and X. Dai. 2007. Characterization of developmental phenotypes of mice deficient for pygopus 2. Genesis, 45:318-32
  Theisen, H., A. Syed, B.T. Nguyen, T. Lukacsovich, J. Purcell, G. P. Srivastava, D. Iron, K. Gaudenz, Q. Nie, R.Y.M. Wan, M.L. Waterman, and J.L. Marsh. 2007. Wingless directly represses DPP morphogen expression via an armadillo/TCF/Brinker complex. PLoS ONE 2:e142
  Arce, L., N.N. Yokoyama and M.L. Waterman. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25:7492-7502
  Li, T. W.-H., J.-H. T. Ting, N. Yokoyama, A. Bernstein, M. van de Wetering, and M.L. Waterman. 2006. WNT activation and alternative promoter repression of LEF1 in colon cancer. Mol. Cell. Biol. 26: 5284-5299
  Jimenez, J.J., G.M. Jang, B.L. Semler and M.L. Waterman. 2005. An internal ribosome entry site mediates translation of Lymphoid enhancer factor-1. RNA 11:1385-1399
  Atcha, F.A., J.E. Munguia., W.-H. Li, K. Hovanes, M.L. Waterman. 2003. A new b-catenin dependent activation domain in T Cell Factor. J Biol Chem 278:16169-16175
  Ishitani, T., S. Kishida, J. Hyodo, N. Oeno, J. Yasuda, M. L. Waterman, H. Shibuya, R.T. Moon, J. Ninomiya-Tsuji, and K. Matsumoto. 2003. The TAK1-NLK MAPK cascade functions in the Wnt-5a/Ca+2 pathway to antagonize Wnt/ß-catenin signaling. Mol. Cell Biol. 23:131-139
  Hovanes, K.H., J.E. Munguia, T. Truong, T. Milovanovic, T.W.H. Li, J. L. Marsh, R.F. Holcombe and M.L. Waterman. 2001. Selective expression of b-catenin-sensitive forms of Lymphoid Enhancer Factor-1 in Colon Cancer. Nature Genetics 28:53-57.
  Hovanes, K.H., T.W.H. Li, and M.L. Waterman. 2000. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res. 28(9):1994-2003.
  Ishitani, T., J. Ninomiya-Tsuji, S.I. Nagai, M. Nishita, M. Meneghini, N. Barker, M. Waterman, B. Bowerman, H. Clevers, H. Shibuya, and K. Matsumoto. 1999. The TAK1-NLK MAP kinase-related pathway antagonizes b-catenin-TCF signalling. Nature. 399:798-802.
  Prieve, M.P. and M.L. Waterman. 1999. Nuclear Localization and formation of b-catenin-Lymphoid Enhancer Factor-1 complexes is not sufficient for activation of gene expression. Mol. Cell. Biol. 19:4503-4515.
Other Experience Chair
NIH Cancer And Molecular Pathology (CAMP) study section 2014—2016

American Cancer Society Council for Extramural Grants 2010—2014

Graduate Programs Cellular and Molecular Biosciences

Research Centers UCI Chao Family Comprehensive Cancer Center
Center for Complex Biological Systems
Sue and Bill Gross Stem Cell Center
Institute for Immunology
Link to this profile
Last updated 01/26/2015